High-dose intravenous immunoglobulin therapy in juvenile myasthenia gravis
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Pediatric Neurology
- Vol. 22 (1) , 40-43
- https://doi.org/10.1016/s0887-8994(99)00112-5
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Clinical trial of plasma exchange and high‐dose intravenous immunoglobulin in myasthenia gravisAnnals of Neurology, 1997
- Cerebral infarction complicating intravenous immunoglobulin therapy for polyneuritis cranialisNeurology, 1992
- Theoretical mechanisms by which immunoglobulin therapy might benefit myasthenia gravisClinical Immunology and Immunopathology, 1989
- Hemolysis following intravenous immune globulin therapyTransfusion, 1986
- NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULINThe Lancet, 1986
- Myasthenia gravis and myasthenic syndromesAnnals of Neurology, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVISThe Lancet, 1984
- HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR MYASTHENIA GRAVISThe Lancet, 1984
- Anti-acetylcholine receptor antibodies in myasthenia gravisJournal of the Neurological Sciences, 1983
- Functional Activities of Autoantibodies to Acetylcholine Receptors and the Clinical Severity of Myasthenia GravisNew England Journal of Medicine, 1982